TNFRSF9 and melanoma: In anti-4-1BB–treated B16-SIY melanoma-bearing mice, the frequency of CD73+ cells among both tumor-infiltrating CD4+ and CD8+ T cells was considerably reduced, which was explained largely by a favorable expansion of CD73− T cell compartment in response to 4-1BB ligation.